BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 11, 2020
View Archived Issues
How stress disrupts tumor cell sleep
Read More
Specific PARP1-PROTAC degrader shows anticancer activity in preclinical models
Read More
Formycon reports preclinical data on FYB-207 for COVID-19
Read More
Fluvoxamine may prevent clinical deterioration in mild symptomatic COVID-19 compared with placebo
Read More
NGM discloses novel antagonist antibody inhibiting LAIR1 for advanced solid tumors
Read More
Positive pivotal phase III data for Epolong in CKD
Read More
First patient dosed in pivotal ENVASARC study of envafolimab
Read More
Positive topline data presented from ULTIMATE I and II studies of ublituximab
Read More
PureTech initiates proof-of-concept study of LYT-100 in lymphedema
Read More
Pharvaris discovers B2 bradykinin receptor antagonists
Read More
New IDO-1 inhibitors presented by BeiGene
Read More
Shanghai Daoshang Biology Tech, Shanghai Medicilon patent MNK1 and MNK2 inhibitors
Read More
Mutant EGFR inhibitors presented by Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical
Read More
New SSAO inhibitors identified at Sunshine Lake Pharma
Read More
AbbVie reports phase IIIb head-to-head data on upadacitinib in atopic dermatitis
Read More
Hoth receives Australian clearance for phase Ib trial of BioLexa for atopic dermatitis
Read More
Variants in KCNH2 gene as predictive biomarkers of SUDEP risk
Read More
Bellicum initiates phase I/II trial of BPX-603 for HER2-positive tumors
Read More
Targeting filamin A reduces seizures in models of focal cortical malformations
Read More
TaiGen advances influenza antiviral TG-1000 into phase II study
Read More
WVE-004 developed as stereopure antisense oligonucleotide for C9orf72-associated ALS and FTD
Read More
Ascentage reports clinical data on APG-2575 in CLL
Read More
Fera to assess naproxcinod as adjuvant treatment for patients with COVID-19
Read More
Neoleukin submits IND application for NL-201 for relapsed or refractory solid tumors
Read More
Passage Bio receives first clearance for PBGM-01 clinical trial program for GM1 gangliosidosis
Read More
DNA nanostructure molecular gate allows protein-controlled transport of drugs
Read More